Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A screening method for gs expression system cell line

An expression system and screening method technology, applied in the field of high-throughput screening of GS expression system cell lines, can solve the problems of long experimental period, heavy workload, cumbersome operation, etc., and achieve shortened screening period, high clone formation rate and stable sex-enhancing effect

Inactive Publication Date: 2019-06-25
SUNSHINE LAKE PHARM CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The most common method for monoclonal screening is limiting dilution cloning (LDC), which is low-cost and easy to operate, that is, the cell density is 95% Cell pool, the highest cloning efficiency is only about 7%, and the average level is 3% to 4%, and the operation is cumbersome, the workload is heavy, the experiment period is long, the experiment efficiency is low, and high-throughput screening cannot be achieved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A screening method for gs expression system cell line
  • A screening method for gs expression system cell line
  • A screening method for gs expression system cell line

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 Preparation of cell pool A and monoclonal screening of cell pool A for stable cell lines with high expression

[0032] 1. Construction of expression constructs

[0033] Referring to WO 2007 / 014162 A2 patent and GS Xceed TM The Gene Expression System (purchased from Lonza Company) was used to independently prepare the Anti-VEGF humanized antibody GS double gene expression vector.

[0034] 2. Transfection of Mammalian Cells

[0035] use HiPure Plasmid DNA Purification Kit (Invitrogen, K2100-04) was used to extract the double-gene expression vector of Anti-VEGF humanized antibody, linearized and purified by PvuI (TaKaRa, 1242A), and the total amount of 40 μg DNA / electroporation system was used CHOK1SV GS-KO cells (Lonza, GS Xceed TM GeneExpression System), resuspend the cells after three electric shocks in a 125mL conical culture flask (corning, 431143-50EA) containing 30mL CD CHO Medium (Invitrogen, 12490-25), 140rmp, 37°C, 8.0% CO 2 Shaking culture under c...

Embodiment 2

[0073] Example 2 Preparation of Cell Pool B and Cell Pool B Monoclonal Screening for High Expression Stable Cell Lines

[0074] 1. Construction of expression constructs

[0075] Referring to WO 2007 / 014162A2 patent and GS Xceed TM The Gene Expression System (purchased from Lonza Company) was used to independently prepare the Anti-VEGF humanized antibody GS double gene expression vector.

[0076] 2. Transfection of Mammalian Cells

[0077] use HiPure Plasmid DNA Purification Kit (Invitrogen, K2100-04) was used to extract the double-gene expression vector of Anti-VEGF humanized antibody, linearized and purified by PvuI (TaKaRa, 1242A), and the total amount of 40 μg DNA / electroporation system was used CHOK1SV GS-KO cells (Lonza, GS Xceed TM GeneExpression System), resuspend the cells after three electric shocks in a 125mL conical culture flask (corning, 431143-50EA) containing 30mL CD CHO Medium (Invitrogen, 12490-25), 140rmp, 37°C, 8.0% CO 2 Shaking culture under condition...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a screening method of a cell strain of a GS expression system. The method includes the steps of: pressurizing methionine sulphoximine, selecting a cell pool being 25-35% in cell activity for performing monoclonal screening, and adding the cell pool to a semi-solid culture medium containing 10% of a conditional culture medium to form mono-clone (wherein final cell concentration is 150 cells / ml), and then performing screening and amplified cultivation to obtain a high-expression cell strain through a high-throughput cell screening system, and performing stability evaluation to the screened high-expression cell strain. The method can be used for obtaining the cell strain being more than 90% in stability.

Description

technical field [0001] The invention relates to the field of cell engineering, in particular to a high-throughput screening method for GS expression system cell lines. technical background [0002] Lonza's glutamate synthetase (glutamine sythetase, GS) expression system came out in 1992 and has been improved. This system inserts foreign genes into the downstream of the GS gene expression vector, and host cells can choose endogenous non- Recombinant mouse myeloma cells NS0 expressing GS gene and Chinese hamster ovary cell CHOK1SV GS-KO of GS gene knockout type were added with GS inhibitor aminosulfomethionine (methioninesulfoximine, MSX) during cell culture to make GS gene and The connected target gene can be amplified together to achieve the purpose of increasing the expression level of the target gene. So far, Lonza's GS expression system has been widely used in the biopharmaceutical industry, including the marketed (Roche) and (Medimmune). [0003] The purpose of cel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/85C12N15/65
CPCC12N15/65C12N15/85C12N2800/107
Inventor 刘静张彩霞李扬杨彬孙文正倪健
Owner SUNSHINE LAKE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com